OasisLMS

In this one-hour event, an expert panel of oncology care professionals discuss ways to identify ideal care recommendations for individuals with Stage IB-IIIA non-small cell lung cancer (NSCLC) amid rapidly advancing clinical data. Explore emerging trends, including considerations for neoadjuvant and/or adjuvant treatment, radiation in patients with early-stage NSCLC, and the role of navigators in care coordination from diagnosis to post-treatment care. A live Q&A session towards the end of the discussion will give participants the opportunity to consult with experts as well.

Objectives:

• Explore recent updates in the treatment of patients with early-stage NSCLC
• Examine care coordination challenges and opportunities
• Highlight the importance of patient navigation

Don’t miss this opportunity to engage with experts in the field of NSCLC. Register today!

The ACCC education program, Changing Care Patterns for Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC), is supported by AstraZeneca.

Xiuning Le, MD, PhD
Deputy Section Chief of Thoracic Medical Oncology, Associate Professor
The University of Texas MD Anderson Cancer Center

Percy Lee, MD, FASTRO
Medical Director, Professor and Vice-Chair of Clinical Research
City of Hope- Orange County

Jennifer Aversano, MSN, RN, OCN, ONN-CG
Oncology Nurse Navigator-Lung
Northwest Community Hospital